SCHEMBL14205193

SCHEMBL14205193

C1=CC2=C(CC1)CCNC2

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.33
CD44 P16070 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23507847 0.88 PNMT (0.30) PNMT
SCHEMBL24384896 0.84 HTR2C (0.31)
SCHEMBL8279313 0.83 PNMT (0.31) PNMTCD44MAOB
SCHEMBL8239929 0.82
SCHEMBL24765325 0.75
SCHEMBL19241137 0.72
SCHEMBL17968444 0.71
SCHEMBL6301684 0.68 CRBN (0.36)
SCHEMBL17734069 0.68 PNMT (0.32) PNMTCD44MAOB
SCHEMBL9987289 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260185-B Deuterated derivative of corydaline and stephanine and preparation method thereof 杨征 2024-09-24 CN disclosed
CN-112812112-B Preparation method of isoquinoline alkaloid L-corydaline 杨征 2024-06-28 CN disclosed
WO-2021163629-A1 INHIBITORS OF ULK1/2 AND METHODS OF USING SAME SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-08-19 WO disclosed
EP-3197883-B1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2020-03-18 EP disclosed
CN-110156789-A A kind of synthetic method of azacyclo- and quinazoline compounds 东华理工大学 2019-08-23 CN disclosed
EP-2430019-B1 COMPOUNDS WITH TWO FUSED BICYCLIC HETEROARYL MOIETIES AS MODULATORS OF LEUKOTRIENE A4 HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2013-09-18 EP disclosed
WO-2008051637-A2 PYRIDAZINONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2008-05-02 WO disclosed